Discovery of Potent, Selective and Efficacious Aminopyrazole Inhibitors of PLK4

View Full Paper

Ask AI

Bookmark

Tumor regression noted with PLK4 inhibitor in neuroblastoma models, with significant efficacy observed.
High-throughput screening identified key compounds for optimization leading to improved effectiveness.
Structural analysis guided the design of selective inhibitors that target Polo-like kinase 4 specifically.
Inhibitors may provide new avenues for treating cancers with specific genetic profiles, highlighting their therapeutic relevance.

Discussion

No takes yet. Share an insight, caveat, or question.

Optimized inhibitors of PLK4 demonstrate tumor regression in neuroblastoma, suggesting therapeutic potential against synthetically lethal targets.

Bhattarai et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Optimized inhibitors of PLK4 demonstrate tumor regression in neuroblastoma, suggesting therapeutic potential against synthetically lethal targets.